Considering damage biomarkers together with functional biomarkers such as CysC and proenkephalin A can aid in accurately diagnosing AKI, differentiating pathophysiologic pathways, demonstrating AKI etiology, and grading AKI severity [7]. This evidence concerns the gene PENK and acute kidney injury.